当前位置:首页 - 行情中心 - 科兴制药(688136) - 财务分析 - 现金流量表

科兴制药

(688136)

  

流通市值:74.79亿  总市值:74.79亿
流通股本:2.01亿   总股本:2.01亿

现金流量表

报告期2025-09-302025-06-302025-03-312024-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金901,682,476.95594,413,026.63304,402,163.861,146,887,816.23
  收到的税费返还1,350,046.21133,574.5499,647.31498,482.65
  收到其他与经营活动有关的现金26,422,211.7511,972,199.156,118,879.5752,289,583.69
  经营活动现金流入小计929,454,734.91606,518,800.32310,620,690.741,199,675,882.57
  购买商品、接受劳务支付的现金276,678,071.15158,054,812.7268,088,184.9189,659,020.82
  支付给职工以及为职工支付的现金177,754,043.27115,678,074.7652,258,457.22223,605,975.34
  支付的各项税费43,084,190.7529,398,545.5320,088,985.7661,005,781.69
  支付其他与经营活动有关的现金439,195,957.93273,589,284.58144,739,915.22618,735,368.31
  经营活动现金流出小计936,712,263.1576,720,717.59285,175,543.11,093,006,146.16
  经营活动产生的现金流量净额-7,257,528.1929,798,082.7325,445,147.64106,669,736.41
二、投资活动产生的现金流量:
  收回投资收到的现金1,334,743,697.83801,850,000344,850,0001,947,494,135.36
  取得投资收益收到的现金12,878,974.888,537,534.554,032,679.489,895,037.61
  处置固定资产、无形资产和其他长期资产收回的现金净额1,158,970952,97030,00038,125
  处置子公司及其他营业单位收到的现金净额13,499,888.7413,499,888.74--
  收到的其他与投资活动有关的现金557,000170,00015,0001,891,200
  投资活动现金流入小计1,362,838,531.45825,010,393.29348,927,679.481,959,318,497.97
  购建固定资产、无形资产和其他长期资产支付的现金50,637,515.7629,948,715.588,281,017.9393,991,409.64
  投资支付的现金1,465,850,000995,850,000450,850,0001,955,862,380
  取得子公司及其他营业单位支付的现金1,072,440---
  支付其他与投资活动有关的现金1,142,000577,000133,00013,590,050
  投资活动现金流出小计1,518,701,955.761,026,375,715.58459,264,017.932,063,443,839.64
  投资活动产生的现金流量净额-155,863,424.31-201,365,322.29-110,336,338.45-104,125,341.67
三、筹资活动产生的现金流量:
  吸收投资收到的现金19,250,80019,250,800-6,964,520
  取得借款收到的现金709,641,541.72420,679,579.9176,879,579.9627,655,263.9
  收到其他与筹资活动有关的现金118,847.04118,847.04--
  筹资活动现金流入小计729,011,188.76440,049,226.94176,879,579.9634,619,783.9
  偿还债务支付的现金526,862,283.43287,615,207.89143,597,465.44559,465,826.85
  分配股利、利润或偿付利息支付的现金46,721,329.2136,442,873.6710,289,110.1443,634,014.88
  支付其他与筹资活动有关的现金55,042,650.9652,175,523.772,328,679.9142,434,149.36
  筹资活动现金流出小计628,626,263.6376,233,605.33156,215,255.49645,533,991.09
  筹资活动产生的现金流量净额100,384,925.1663,815,621.6120,664,324.41-10,914,207.19
四、汇率变动对现金及现金等价物的影响786,051.791,033,973.31449,313.931,391,169.29
五、现金及现金等价物净增加额-61,949,975.55-106,717,644.64-63,777,552.47-6,978,643.16
  加:期初现金及现金等价物余额552,951,942.59552,951,942.59553,198,403.29559,930,585.75
  期末现金及现金等价物余额491,001,967.04446,234,297.95489,420,850.82552,951,942.59
补充资料:
  净利润-78,962,472.06-27,048,555.4
  资产减值准备-978,079.61-3,669,050.48
  固定资产和投资性房地产折旧-34,413,663.76-67,067,060.21
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-34,413,663.76-67,067,060.21
  无形资产摊销-13,145,669.75-20,806,116.93
  长期待摊费用摊销-3,024,930.59-5,897,822.15
  处置固定资产、无形资产和其他长期资产的损失-114,723.4--77,059.28
  固定资产报废损失-113,238.67-172,386.94
  公允价值变动损失--15,439,757.31-29,188,617.47
  财务费用-20,135,472.81-43,357,485.96
  投资损失--23,535,525.66--9,538,871.79
  递延所得税-2,270,936.03-12,877,959.59
  其中:递延所得税资产减少-953,775.1-16,758,057.1
    递延所得税负债增加-1,317,160.93--3,880,097.51
  存货的减少-11,930,587.07-45,886,448.54
  经营性应收项目的减少--95,968,022.08--228,070,473.68
  经营性应付项目的增加--13,694,468.57-69,458,817.36
  其他-6,658,137-4,366,892.5
  现金的期末余额-446,234,297.95-552,951,942.59
  减:现金的期初余额-552,951,942.59-559,930,585.75
  现金及现金等价物的净增加额--106,717,644.64--6,978,643.16
公告日期2025-10-302025-08-232025-04-282025-04-11
审计意见(境内)标准无保留意见
TOP↑